AKT1 and colorectal carcinoma: These findings are compatible with the idea that the PI3K-AKT pathway might trigger the EMT process by downregulating epithelial markers, while upregulating mesenchymal markers and EMT-specific transcription factors, thereby promoting CRC invasion, migration, and resistance [76, 77].